Open label, non-randomized, multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1 (c259)t in HLA-A2(+) patients with synovial sarcoma (NCT01343043) Meeting Abstract

  

Authors:	Mackall, C.; Tap, W. D.; Glod, J.; Druta, M.; Chow, W. A.; Araujo, D. M.; Grupp, S. A.; Van Tine, B. A.; Chagin, K.; Van Winkle, E.; Kari, G.; Trivedi, T.; Norry, E.; Holdich, T.; Bartlett-Pandite, A. N.; Amado, R. G.; D'Angelo, S. P.
Abstract Title:	Open label, non-randomized, multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1 (c259)t in HLA-A2(+) patients with synovial sarcoma (NCT01343043)
Meeting Title:	53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	35
Issue:	15 Suppl.
Meeting Dates:	2017 Jun 2-6
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2017-05-20
Start Page:	138s
Language:	English
ACCESSION:	WOS:000411895705130
DOI:	10.1200/JCO.2017.35.15_suppl.3000
PROVIDER:	wos
Notes:	Meeting Abstract: 3000 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/147206